McKesson balance sheet
At the end of fiscal 2026, McKesson had total assets of $82.32bn and shareholders' equity of −$2.17bn. It held $3.98bn in cash against $6.53bn of debt: net debt of $2.55bn.
Balance sheet
| Fiscal year | 2010Mar 2010 | 2011Mar 2011 | 2012Mar 2012 | 2013Mar 2013 | 2014Mar 2014 | 2015Mar 2015 | 2016Mar 2016 | 2017Mar 2017 | 2018Mar 2018 | 2019Mar 2019 | 2020Mar 2020 | 2021Mar 2021 | 2022Mar 2022 | 2023Mar 2023 | 2024Mar 2024 | 2025Mar 2025 | 2026Mar 2026 | LTMJun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 3.7 | 3.6 | 3.1 | 2.5 | 4.2 | 5.3 | 4.0 | 2.8 | 2.7 | 3.0 | 4.0 | 6.3 | 3.5 | 4.7 | 4.6 | 5.7 | 4.0 | 5.2 |
| Receivables | 8.1 | 9.2 | 10.0 | 10.0 | 13.8 | 15.9 | 18.0 | 18.2 | 17.7 | 18.2 | 20.0 | 19.2 | 18.6 | 19.4 | 21.6 | 25.6 | 28.0 | 30.3 |
| Inventory | 9.4 | 9.2 | 10.1 | 10.3 | 13.0 | 14.3 | 15.3 | 15.3 | 16.3 | 16.7 | 16.7 | 19.2 | 18.7 | 19.7 | 21.1 | 23.0 | 24.2 | 26.3 |
| Total current assets | 21.5 | 22.4 | 23.6 | 23.2 | 32.8 | 36.7 | 38.4 | 36.9 | 37.1 | 38.5 | 42.2 | 45.4 | 46.2 | 44.3 | 48.0 | 55.4 | 57.2 | 62.8 |
| Goodwill | 3.6 | 4.4 | 5.0 | 6.4 | 9.9 | 9.8 | 9.8 | 10.6 | 10.9 | 9.4 | 9.4 | 9.5 | 9.5 | 9.9 | 10.1 | 10.0 | 11.3 | 11.3 |
| Total assets | 28.2 | 30.9 | 33.1 | 34.8 | 51.8 | 53.9 | 56.5 | 61.0 | 60.4 | 59.7 | 61.2 | 65.0 | 63.3 | 62.3 | 67.4 | 75.1 | 82.3 | 88.3 |
| Accounts payable | 13.3 | 14.1 | 16.1 | 16.1 | 21.1 | 25.2 | 28.6 | 31.0 | 32.2 | 33.9 | 37.2 | 39.0 | 38.1 | 42.5 | 47.1 | 55.3 | 60.0 | 63.7 |
| Deferred revenue (current) | 1.2 | 1.3 | 1.4 | 1.4 | 1.2 | 1.1 | 0.9 | 0.3 | 0.1 | — | — | — | — | — | — | — | — | — |
| Total current liabilities | 17.0 | 18.7 | 21.7 | 21.4 | 29.6 | 33.5 | 35.1 | 35.6 | 36.7 | 37.6 | 42.6 | 44.1 | 48.5 | 48.0 | 52.4 | 61.6 | 67.0 | 70.4 |
| Short-term debt | 0.0 | 0.4 | 0.5 | 0.0 | 1.4 | 1.5 | 1.6 | 1.1 | 1.1 | 0.3 | 1.1 | 0.0 | 0.0 | 0.0 | 0.0 | — | — | — |
| Long-term debt | 2.3 | 3.6 | 3.1 | 4.9 | 8.9 | 8.2 | 6.5 | 7.3 | 6.8 | 7.3 | 6.3 | 6.4 | 5.9 | 5.6 | 5.6 | 5.7 | 6.5 | 9.7 |
| Total debt | 2.3 | 4.0 | 3.6 | 4.9 | 10.6 | 9.8 | 8.1 | 8.5 | 7.9 | 7.6 | 7.4 | 7.1 | 5.9 | 5.6 | 5.6 | 5.7 | 6.5 | 9.7 |
| Shareholders' equity | 7.5 | 7.2 | 6.8 | 7.1 | 8.5 | 8.0 | 8.9 | 11.1 | 9.8 | 8.1 | 5.1 | −0.0 | −2.3 | −1.9 | −2.0 | −2.1 | −2.2 | −4.2 |
| Net debt (negative = net cash) | −1.4 | 0.4 | 0.4 | 2.4 | 6.4 | 4.5 | 4.1 | 5.8 | 5.2 | 4.6 | 3.4 | 0.9 | 2.4 | 0.9 | 1.0 | 0.0 | 2.6 | 4.6 |
| Quarter | 2025 Q2Sept 2024 | 2025 Q3Dec 2024 | 2025 Q4Mar 2025 | 2026 Q1Jun 2025 | 2026 Q2Sept 2025 | 2026 Q3Dec 2025 | 2026 Q4Mar 2026 | 2027 Q1Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Receivables | 25.3 | 25.8 | 25.6 | 28.2 | 28.3 | 28.2 | 28.0 | 30.3 |
| Inventory | 24.2 | 23.8 | 23.0 | 25.1 | 26.1 | 27.1 | 24.2 | 26.3 |
| Total current assets | 53.3 | 51.7 | 55.4 | 56.8 | 59.9 | 59.7 | 57.2 | 62.8 |
| Goodwill | 10.1 | 10.0 | 10.0 | 11.4 | 11.3 | 11.3 | 11.3 | 11.3 |
| Total assets | 72.4 | 71.1 | 75.1 | 81.3 | 84.2 | 84.2 | 82.3 | 88.3 |
| Accounts payable | 53.3 | 49.7 | 55.3 | 57.9 | 60.9 | 60.7 | 60.0 | 63.7 |
| Total current liabilities | 58.8 | 58.6 | 61.6 | 64.3 | 68.0 | 68.1 | 67.0 | 70.4 |
| Short-term debt | — | 2.4 | — | — | — | — | — | — |
| Long-term debt | 5.7 | 5.6 | 5.7 | 7.8 | 7.8 | 6.6 | 6.5 | 9.7 |
| Total debt | 5.7 | 8.0 | 5.7 | 7.8 | 7.8 | 6.6 | 6.5 | 9.7 |
| Shareholders' equity | −3.0 | −3.1 | −2.1 | −2.0 | −1.7 | −1.3 | −2.2 | −4.2 |
Compare with peers
- Cencora balance sheet
- Henry Schein balance sheet
- 111, Inc. balance sheet
- Cosmos Health Inc. balance sheet
- Cellyan Biotechnology Co., Ltd balance sheet
Head to head: COR vs MCKHSIC vs MCKMCK vs YI
More: Health Care Distributors stocks compared, Health Care sector, rankings of US companies